Enwei Pharmaceutical Co., Ltd. (SHE:301331)
31.14
-0.86 (-2.69%)
At close: Oct 29, 2025
Enwei Pharmaceutical Company Description
Enwei Pharmaceutical Co., Ltd. develops and sells Chinese medicines in China.
It offers drugs in the areas of gynecology, pediatrics, respiratory system, and other pharmaceutical fields.
The company was founded in 2005 and is based in Chengdu, China.
Enwei Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2005 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,548 |
| CEO | Yongjiang Xue |
Contact Details
Address: No. 458, Shuanghua Road Chengdu, 610200 China | |
| Phone | 86 28 8154 8888 |
| Website | enwei.com.cn |
Stock Details
| Ticker Symbol | 301331 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yongjiang Xue | Chief Executive Officer |
| Dawei Hu | Chief Financial Officer |